Skip to main content

Table 4 Patient-reported adverse events

From: Artemether–lumefantrine and dihydroartemisinin–piperaquine treatment outcomes among children infected with uncomplicated Plasmodium falciparum malaria in Mwanza, Tanzania

Adverse effect

ALU

DHP

Patient reported

N (%)

Patient reported

N (%)

Headache (yes) n (%)

98

12 (12.24%)

88

8 (9.09%)

Nausea and vomiting (yes) n (%)

99

14 (14.14%)

87

3 (3.45%)

Cough (yes) n (%)

99

4 (4.04%)

88

0

Diarrhea (yes) n (%)

98

1 (1.02%)

88

3 (3.41%)

Loss appetite (yes) n (%)

93

5 (5.38%)

89

1 (1.12%)

Abdominal pain (yes) n (%)

98

13 (13.27%)

86

7 (8.14%)